Advancing Epilepsy Care
Through Advancing Epilepsy Care, we strive to help all epilepsy patients and their families cope with the difficulties associated with the condition. This includes partial onset seizures, which account for 60% of all seizures, Primary Generalized Tonic-Clonic (PGTC) seizures, one of the most common and severe forms of generalized seizures, and seizures associated with Lennox-Gaustaut Syndrome (LGS), a severe form of early childhood-onset epilepsy. As a company dedicated to Advancing Epilepsy Care for patients and caregivers, Eisai is committed to helping provide educational and practical resources in an effort to help meet the needs of the epilepsy community.
Eisai & human health care (hhc)
At Eisai Inc., human health care is our mission. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., our passionate commitment to patient care is the driving force behind our efforts to help address unmet medical needs. Eisai recognizes that patients and their families are the key players in health care and we strive to consider their perspectives.
Eisai is committed to innovative solutions in disease prevention, treatment, and care for the health and well-being of people worldwide. We believe in the simple principle that patients and their families come first and we have a responsibility to listen to and learn from them; we call it human health care (hhc).